Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Kidney Int
    July 2017
  1. OWENS EA, Jie L, Reyes BAS, Van Bockstaele EJ, et al
    Elastin insufficiency causes hypertension, structural defects and abnormal remodeling of renal vascular signaling.
    Kidney Int. 2017 Jul 26. pii: S0085-2538(17)30352.
    >> Share

    June 2017
  2. TITZE J, Luft FC
    Speculations on salt and the genesis of arterial hypertension.
    Kidney Int. 2017;91:1324-1335.
    >> Share

  3. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    >> Share

    May 2017
  4. RASHMI P, Colussi G, Ng M, Wu X, et al
    Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron.
    Kidney Int. 2017;91:1159-1177.
    >> Share

    April 2017
  5. HOY WE, Kopp JB, Mott SA, Winkler CA, et al
    Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.
    Kidney Int. 2017;91:990.
    >> Share

  6. GIANI JF, Eriguchi M, Bernstein EA, Katsumata M, et al
    Renal tubular angiotensin converting enzyme is responsible for nitro-L-arginine methyl ester (L-NAME)-induced salt sensitivity.
    Kidney Int. 2017;91:856-867.
    >> Share

    February 2017
  7. WEBSTER P, Lightstone L, McKay DB, Josephson MA, et al
    Pregnancy in chronic kidney disease and kidney transplantation.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30748.
    >> Share

  8. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    >> Share

  9. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    >> Share

    January 2017
  10. KOBAYASHI R, Wakui H, Azushima K, Uneda K, et al
    An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
    Kidney Int. 2017 Jan 4. pii: S0085-2538(16)30650.
    >> Share

    December 2016
  11. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    >> Share

  12. WYATT CM, Spence JD
    Folic acid supplementation and chronic kidney disease progression.
    Kidney Int. 2016;90:1144-1145.
    >> Share

    October 2016
  13. VAN DEN BORN BJ, Oskam LC, Zidane M, Schachterle C, et al
    The Case| A handful of hypertension.
    Kidney Int. 2016;90:911-3.
    >> Share

    September 2016
  14. HALLER ST, Kumarasamy S, Folt DA, Wuescher LM, et al
    Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.
    Kidney Int. 2016 Sep 28. pii: S0085-2538(16)30443.
    >> Share

  15. WYATT CM, Chertow GM
    Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?
    Kidney Int. 2016;90:460-2.
    >> Share

    August 2016
  16. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    >> Share

  17. KURTZ TW, DiCarlo SE, Pravenec M, Schmidlin O, et al
    An alternative hypothesis to the widely held view that renal excretion of sodium accounts for resistance to salt-induced hypertension.
    Kidney Int. 2016 Aug 18. pii: S0085-2538(16)30310.
    >> Share

    Hypertension and glomerular function decline: the chicken or the egg?
    Kidney Int. 2016;90:254-6.
    >> Share

    June 2016
  19. WEIR MR, Bakris GL, Gross C, Mayo MR, et al
    Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Kidney Int. 2016 Jun 24. pii: S0085-2538(16)30186.
    >> Share

    May 2016
  20. ERIKSEN BO, Stefansson VT, Jenssen TG, Mathisen UD, et al
    Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30073.
    >> Share

  21. MATHEW AT, Fishbane S, Obi Y, Kalantar-Zadeh K, et al
    Preservation of residual kidney function in hemodialysis patients: reviving an old concept.
    Kidney Int. 2016 May 12. pii: S0085-2538(16)30054.
    >> Share

  22. BETZ BB, Jenks SJ, Cronshaw AD, Lamont DJ, et al
    Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Kidney Int. 2016;89:1125-35.
    >> Share

    April 2016
  23. BENGHANEM GHARBI M, Elseviers M, Zamd M, Belghiti Alaoui A, et al
    Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00369.
    >> Share

    Promising biomarkers for superimposed pre-eclampsia in pregnant women with established hypertension and chronic kidney disease.
    Kidney Int. 2016;89:743-6.
    >> Share

    February 2016
  25. TAVASOLI M, Li L, Al-Momany A, Zhu LF, et al
    The chloride intracellular channel 5A stimulates podocyte Rac1, protecting against hypertension-induced glomerular injury.
    Kidney Int. 2016 Feb 24. pii: S0085-2538(16)00220.
    >> Share

  26. ZAIDAN M, Koumakis E, Karras A, Bruneval P, et al
    The Case | A man with hypertension, respiratory distress, and rapidly progressive renal failure.
    Kidney Int. 2016;89:509-10.
    >> Share

  27. ROCCO MV, Cheung AK
    A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists.
    Kidney Int. 2016;89:261-3.
    >> Share

    January 2016
  28. BRAMHAM K, Seed PT, Lightstone L, Nelson-Piercy C, et al
    Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease.
    Kidney Int. 2016 Jan 19. pii: S0085-2538(15)00127.
    >> Share

  29. FLOEGE J, Rauen T
    Immunosuppression in IgA nephropathy: how certain are we?
    Kidney Int. 2016;89:9-11.
    >> Share

    June 2015
  30. LIAO JN, Chao TF, Liu CJ, Wang KL, et al
    Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.
    Kidney Int. 2015;87:1209-15.
    >> Share

    May 2015
  31. REDDY MA, Natarajan R
    Recent developments in epigenetics of acute and chronic kidney diseases.
    Kidney Int. 2015 May 20. doi: 10.1038/ki.2015.
    >> Share

  32. KU E, Glidden DV, Johansen KL, Sarnak M, et al
    Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.
    Kidney Int. 2015;87:1055-60.
    >> Share

    April 2015
  33. RUMP LC, Stegbauer J
    Coronary artery stenosis: a new risk factor for chronic kidney injury?
    Kidney Int. 2015;87:676-7.
    >> Share

  34. PALLET N, Mami I, Schmitt C, Karim Z, et al
    High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.
    Kidney Int. 2015 Apr 1. doi: 10.1038/ki.2015.
    >> Share

    February 2015
  35. DRECHSLER C, Kalim S, Wenger JB, Suntharalingam P, et al
    Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
    Kidney Int. 2015 Feb 11. doi: 10.1038/ki.2014.
    >> Share

    January 2015
  36. MOLITCH ME, Adler AI, Flyvbjerg A, Nelson RG, et al
    Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.
    Kidney Int. 2015;87:20-30.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016